Evidence map›Paper›PMID 24642345›Full record

Trial reportAddictive behaviors2014

Preliminary evidence for normalization of risk taking by modafinil in chronic cocaine users.

Sofija V Canavan, Erica L Forselius, Andrew J Bessette, Peter T Morgan

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Addictive behaviors, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Psychostimulant drugs for cocaine dependence.The Cochrane database of systematic reviews · 2016
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sofija V CanavanDepartment of Psychiatry, Yale University, Connecticut Mental Health Center, 34 Park St, New Haven, CT 06519, USA. Electronic address: svcanavan@uchicago.edu.
Erica L ForseliusDepartment of Psychiatry, Yale University, Connecticut Mental Health Center, 34 Park St, New Haven, CT 06519, USA. Electronic address: erica.forselius@yale.edu.
Andrew J BessetteDepartment of Psychiatry, Yale University, Connecticut Mental Health Center, 34 Park St, New Haven, CT 06519, USA. Electronic address: andrew.bessette@yale.edu.
Peter T MorganDepartment of Psychiatry, Yale University, Connecticut Mental Health Center, 34 Park St, New Haven, CT 06519, USA. Electronic address: peter.morgan@yale.edu.
Connecticut Mental Health Center · USYale University · US

Funding

Modafinil, sleep architecture, and cocaine relapseR01DA011744 · NIDA · YALE UNIVERSITY · PI MORGAN, PETER T · 1999 to 2014
$4.4M
NIDA NIH HHS R01 DA011744
6 · The paper itself

Abstract

Modafinil, a wake-promoting agent used to treat sleep disorders, is thought to enhance cognition. Although modafinil has shown promise as a pharmacotherapy for the treatment of cocaine dependence, it is unknown to what extent cognitive effects may play a role in such treatment. We examined the effect of modafinil on the Balloon Analogue Risk Task (BART), a behavioral measure in which higher scores are purported to reflect a greater propensity for risk-taking. Thirty cocaine dependent individuals, enrolled in a randomized clinical trial of modafinil 400mg (n=12) versus placebo (n=18), were administered the BART during the second week of inpatient treatment for cocaine dependence. A comparison cohort of healthy participants (n=19) performed the BART under similar conditions. Modafinil treatment was associated with significantly higher BART scores (p=0.01), which were comparable to scores in healthy persons. BART scores in placebo treated participants were much lower than previously reported in healthy participants, and lower than those observed in the comparison cohort. As propensity toward risk taking is typically associated with higher BART scores as well as increased risk for substance use, our findings may reflect a novel aspect of cognitive impairment related to chronic cocaine use. Notably, the low BART scores reflect highly suboptimal performance on the task, and the observed effect of modafinil may indicate a normalization of this impairment and have implications for treatment outcome.

Indexed as

Risk-TakingAdultBenzhydryl CompoundsChronic DiseaseCocaine-Related DisordersCognitionCohort StudiesFemaleHumansMaleModafinilTask Performance and AnalysisWakefulness-Promoting AgentsBenzhydryl CompoundsModafinilWakefulness-Promoting AgentsBalloon Analogue Risk TaskCocaine dependenceCognitionModafinilRisk taking

Identifiers

PMID24642345
PMCPMC4026273
OpenAlexW2056095317

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.